BOSTON--(BUSINESS WIRE)--Orthofix International N.V. (NASDAQ: OFIX) (the Company) announced today that it has signed agreements with the Musculoskeletal Transplant Foundation (MTF) to collaborate on the final development and distribution of a stem cell-based allograft.
